The attorneys of Swanson & Bratschun have extensive experience prosecuting patents and providing IP strategy and planning in the area of pharmaceuticals.  Patent strategy, development and prosecution in the pharmaceutical field requires both an in-depth understanding of the science behind the invention combined with the nuanced navigation through the Patent Office to effectively protect the invention.  The attorneys of Swanson & Bratschun possess both the necessary technical backgrounds and corresponding practical experience to fully understand this duality.  Attorneys at Swanson & Bratschun possess advanced degrees in organic chemistry, pharmacology, toxicology, microbiology, immunology, biomedical sciences, experimental pathology, and cell and molecular biology.  Our clients include those developing products that are regulated by the U.S. Food and Drug Administration and others focusing on unregulated products.  Representative technologies where the attorneys of Swanson & Bratschun have successfully prosecuted inventions in the pharmaceutical field include:

  • Small organic molecules
  • Kinase inhibitors
  • Peptide inhibitors
  • Nutraceuticals
  • Aptamers
  • RNAi
  • Antibodies
  • Prodrugs
  • Various chemical compounds